Chemistry Reference
In-Depth Information
27. Weibel EK, Hadvary P, Hochuli E, Kupfer E, Lengsfeld H. Lipstatin, an inhibitor
of pancreatic lipase, produced by
Streptomyces toxytricini
. J. Antibiot. 1987;40:
1081-1085.
28. Liu DZ, Wang F, Liao TG, Tang JG, Steglich W, Zhu HJ, Liu JK. Vibralactone: a
lipase inhibitor with an unusual fused beta-lactone of the basidiomycete
Boreostereum
vibrans
. Org. Lett. 2006;8:5749-5752.
29. Ondetti MA, Rubin B, Cushman DW. Enzyme of the rennin-angiotensin system and
their inhibitors. Annu. Rev. Biochem. 1982;51:283-308.
30. Rhee KH. Purification and identification of an antifungal agent from
Streptomyces
sp.
KH-614 antagonistic to rice blast fungus,
Pyricularia oryzae
. J. Microbiol. Biotechnol.
2003;13:984-988.
31. Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase
inhibitors. Curr. Med. Chem. 2002;9:195-217.
32. Izumida H, Miki W, Sano H, Endo M. Agar plate method, a new assay for chitinase
inhibitors using a chitin-degrading bacterium. J. Marine Biotechnol. 1995;2:163-166.
33. Song YC, Li H, Ye YH, Shan CY, Yang YM, Tan RX. Endophytic naphthopyrone
metabolites are co-inhibitors of xanthine oxidase, SW1116 cell and some microbial
growths. FEMS Microbiol. Lett. 2004;241:67-72.
34. Paterson RRM. Fungal enzyme inhibitors as pharmaceuticals, toxins and scourge of
PCR. Curr. Enzyme Inhib. 2008;4:46-59.
35. Duke SO, Cantrell CL, Meepagal KM, Wedge DE, Tabanca N, Schrader KK. Natural
toxins for use in pest management. Toxins 2010;2:1943-1962.
36. Strobel G, Sugawara F, Hershenhorn J. Pathogens and their products affecting weedy
plants. Phytoparasitica 1992;20:307-323.
37. Lebenthal Y, Horvath A, Dziechciarz P, Szajewska H, Shamir R. Are treatment targets
for hypercholesterolemia evidence based? Systematic review and meta-analysis of
randomised controlled trials. Arch. Dis. Child. 2010;95:673-680.
38. Barrios-Gonzalez J, Miranda RU. Biotechnological production and applications of
statins. Appl. Microbiol. Biotechnol. 2010;85:869-883.
39. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid
Res. 1992;33:1569-1582.
40. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M,
Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg
G, Hensens O, Hirshfield J, Hoogsteent K, Liesch J, Springer J. Mevinolin: a highly
potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a
cholesterol-lowering agent. Proc. Natl. Acad. Sci. U.S.A. 1980;77:3957-3961.
41. Subazini TK, Kumar GR. Characterization of lovastatin biosynthetic cluster proteins
in
Aspergillus terreus
strain ATCC 20542. Bioinformation 2011;6:250-254.
42. Vaklavas C, Chatzizisis YS, Tsimberidou AM. Common cardiovascular medications
in cancer therapeutics. Pharmacol. Ther. 2011;130:177-190.
43. Bakhireva LN, Shainline MR, Carter S, Robinson S, Beaton SJ, Nawarskas JJ, Gunter
MJ. Synergistic effect of statins and postmenopausal hormone therapy in the preven-
tion of skeletal fractures in elderly women. Pharmacotherapy 2010;30:879-887.
44. Barone E, Cenini G, Di Domenico F, Martin S, Sultana R, Mancuso C, Murphy MP,
Head E, Butterfield DA. Long-term high-dose atorvastatin decreases brain oxidative
and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism
of action. Pharmacol. Res. 2011;63:172-180.
